Literature DB >> 5658587

In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids.

J B Field, A Remer, G Bloom, J P Kriss.   

Abstract

Long-acting thyroid stimulator (LATS) increased glucose oxidation and (32)P incorporation into phospholipids in in vitro experiments with dog thyroid slices. The time course of the response was different from that obtained with thyroid-stimulating hormone (TSH), but was very similar to the delayed effect observed in vivo. During a 45 min incubation, TSH, but not LATS increased glucose oxidation, whereas in longer experiments up to 6 hr, both substances augmented (14)CO(2) production. Amounts of pooled human gamma globulin equivalent to LATS were inactive. Although TSH stimulated (32)P incorporation into phospholipids during a 2 hr incubation, LATS was ineffective. In longer incubations, from 4(1/2) to 8 hr, LATS did increase (32)P incorporation. The stimulatory effect of LATS was not abolished by anti-TSH antibody capable of neutralizing human TSH. Effects of LATS were also obtained with beef and pig thyroid slices. In addition to stimulation of glucose oxidation in dog thyroid slices, LATS occasionally also stimulated glucose oxidation in dog spleen and liver slices. Despite a 54-fold increase in LATS concentration, a satisfactory dose-response curve could not be demonstrated when (14)CO(2) production was measured.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5658587      PMCID: PMC297313          DOI: 10.1172/JCI105847

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.

Authors:  A Lepp; L Oliner
Journal:  Endocrinology       Date:  1967-02       Impact factor: 4.736

2.  Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis.

Authors:  L Carneiro; K J Dorrington; D S Munro
Journal:  Lancet       Date:  1966-10-22       Impact factor: 79.321

3.  Activation of adenyl cyclase in thyroid homogenates by thyroid-stimulating hormone.

Authors:  I Pastan; R Katzen
Journal:  Biochem Biophys Res Commun       Date:  1967-12-29       Impact factor: 3.575

Review 4.  The long-acting thyroid stimulator: its role in Graves' disease.

Authors:  J M McKenzie
Journal:  Recent Prog Horm Res       Date:  1967

5.  Comparison of early effects of thyrotropin and long-acting thyroid stimulator on thyroid secretion.

Authors:  Y Shishiba; D H Solomon; G N Beall
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

6.  Effects of ions on TSH stimulation of P-32 incorporation into thyroid slice phospholipid.

Authors:  H Oka; J B Field
Journal:  Am J Physiol       Date:  1966-12

7.  The effect of dibutyryl cyclic 3',5'-AMP on the thyroid.

Authors:  I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1966-10-05       Impact factor: 3.575

8.  Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.

Authors:  G N Beall; D H Solomon
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

9.  Comparative effects of long-acting thyroid stimulator and pituitary thyrotropin on the intermediate metabolism of thyroid tissue in vitro.

Authors:  T W Scott; B F Good; K A Ferguson
Journal:  Endocrinology       Date:  1966-11       Impact factor: 4.736

10.  Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.

Authors:  F O Berumen; I L Lobsenz; R D Utiger
Journal:  J Lab Clin Med       Date:  1967-10
View more
  2 in total

1.  Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.

Authors:  K Yamashita; J B Field
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

Review 2.  Recent advances in organotypic tissue slice cultures for anticancer drug development.

Authors:  Lin He; Chuxia Deng
Journal:  Int J Biol Sci       Date:  2022-09-25       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.